Immuno-PET Imaging of Tumour PD-L1 Expression in Glioblastoma

SIMPLE SUMMARY: Almost all patients with glioblastoma (GBM) eventually relapse, mainly due to adaptive and acquired resistance that results from tumour heterogeneity and its relatively immune-depleted (“cold”) microenvironment. High levels of programmed death ligand-1 (PD-L1) have been associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Gitanjali, Braga, Marta C., Da Pieve, Chiara, Szopa, Wojciech, Starzetz, Tatjana, Plate, Karl H., Kaspera, Wojciech, Kramer-Marek, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295898/
https://www.ncbi.nlm.nih.gov/pubmed/37370741
http://dx.doi.org/10.3390/cancers15123131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295898/
https://www.ncbi.nlm.nih.gov/pubmed/37370741
http://dx.doi.org/10.3390/cancers15123131

Ejemplares similares